Cargando…

11. Missed Vaccine Opportunities During the COVID-19 Pandemic

BACKGROUND: The 23-valent pneumococcal polysaccharide vaccine (PPSV23) is recommended for all adults over the age of 65 to reduce S. pneumoniae pneumonia. Our institution follows a standing order for nurses to vaccinate adults who meet the Advisory Committee on Immunization Practices (ACIP) criteria...

Descripción completa

Detalles Bibliográficos
Autores principales: Shallal, Anita, Vahia, Amit T, Kenney, Rachel, Weinmann, Allison J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776057/
http://dx.doi.org/10.1093/ofid/ofaa439.056
_version_ 1783630592217186304
author Shallal, Anita
Vahia, Amit T
Kenney, Rachel
Weinmann, Allison J
author_facet Shallal, Anita
Vahia, Amit T
Kenney, Rachel
Weinmann, Allison J
author_sort Shallal, Anita
collection PubMed
description BACKGROUND: The 23-valent pneumococcal polysaccharide vaccine (PPSV23) is recommended for all adults over the age of 65 to reduce S. pneumoniae pneumonia. Our institution follows a standing order for nurses to vaccinate adults who meet the Advisory Committee on Immunization Practices (ACIP) criteria. During the COVID-19 pandemic surge, the pneumococcal vaccine and influenza vaccine nurse-driven protocol was determined to be non-essential on 3/23, and 4/2 respectively. Our study aims to characterize missed vaccine opportunities among patients hospitalized with COVID-19 during this surge. METHODS: A retrospective cross-sectional study of PCR-positive COVID-19 patients admitted to an inner-city hospital and discharged alive between the dates of 3/23 and 4/21/2020. Patients under the age of 65 were excluded. Data collected included patient age, gender, race, length of stay, co-morbidities that would indicate a vaccine opportunity, prior vaccinations, and whether there was a vaccine opportunity for PPSV23 and influenza defined by ACIP indications. Vaccine history was evaluated using the electronic medical record (EMR) and Michigan Care Improvement Registry. If there was a vaccine opportunity, we documented whether a vaccine was given before hospital discharge. Total numbers of vaccines given for time periods in 2019 and 2020 were collected from EMR for comparison. RESULTS: 100 patients over the age of 65 were included. The average age was 72.8 years, and most patients (66%) were of African American race. The mean length of stay was five days. 52 patients were identified as having an opportunity to receive PPSV23, and 0 patients received the vaccine. 67.3% had more than one indication for PPSV23. 37 patients were eligible to receive influenza vaccine, and 0 received the vaccine. Results are summarized in table 1. Figures 1 and 2 display the number of pneumococcal and influenza vaccines given per EMR, respectively. Figure 1 [Image: see text] Figure 2 [Image: see text] Table 1 [Image: see text] CONCLUSION: Due to prioritization of potential staffing shortages and clustering nursing care, an opportunity to vaccinate patients with pneumococcal and influenza vaccines was missed. It is important for health care providers to be aware of this potential opportunity for vaccination of high-risk patients in order to promote primary prevention in future waves of pandemics. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-7776057
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77760572021-01-07 11. Missed Vaccine Opportunities During the COVID-19 Pandemic Shallal, Anita Vahia, Amit T Kenney, Rachel Weinmann, Allison J Open Forum Infect Dis Poster Abstracts BACKGROUND: The 23-valent pneumococcal polysaccharide vaccine (PPSV23) is recommended for all adults over the age of 65 to reduce S. pneumoniae pneumonia. Our institution follows a standing order for nurses to vaccinate adults who meet the Advisory Committee on Immunization Practices (ACIP) criteria. During the COVID-19 pandemic surge, the pneumococcal vaccine and influenza vaccine nurse-driven protocol was determined to be non-essential on 3/23, and 4/2 respectively. Our study aims to characterize missed vaccine opportunities among patients hospitalized with COVID-19 during this surge. METHODS: A retrospective cross-sectional study of PCR-positive COVID-19 patients admitted to an inner-city hospital and discharged alive between the dates of 3/23 and 4/21/2020. Patients under the age of 65 were excluded. Data collected included patient age, gender, race, length of stay, co-morbidities that would indicate a vaccine opportunity, prior vaccinations, and whether there was a vaccine opportunity for PPSV23 and influenza defined by ACIP indications. Vaccine history was evaluated using the electronic medical record (EMR) and Michigan Care Improvement Registry. If there was a vaccine opportunity, we documented whether a vaccine was given before hospital discharge. Total numbers of vaccines given for time periods in 2019 and 2020 were collected from EMR for comparison. RESULTS: 100 patients over the age of 65 were included. The average age was 72.8 years, and most patients (66%) were of African American race. The mean length of stay was five days. 52 patients were identified as having an opportunity to receive PPSV23, and 0 patients received the vaccine. 67.3% had more than one indication for PPSV23. 37 patients were eligible to receive influenza vaccine, and 0 received the vaccine. Results are summarized in table 1. Figures 1 and 2 display the number of pneumococcal and influenza vaccines given per EMR, respectively. Figure 1 [Image: see text] Figure 2 [Image: see text] Table 1 [Image: see text] CONCLUSION: Due to prioritization of potential staffing shortages and clustering nursing care, an opportunity to vaccinate patients with pneumococcal and influenza vaccines was missed. It is important for health care providers to be aware of this potential opportunity for vaccination of high-risk patients in order to promote primary prevention in future waves of pandemics. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7776057/ http://dx.doi.org/10.1093/ofid/ofaa439.056 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Abstracts
Shallal, Anita
Vahia, Amit T
Kenney, Rachel
Weinmann, Allison J
11. Missed Vaccine Opportunities During the COVID-19 Pandemic
title 11. Missed Vaccine Opportunities During the COVID-19 Pandemic
title_full 11. Missed Vaccine Opportunities During the COVID-19 Pandemic
title_fullStr 11. Missed Vaccine Opportunities During the COVID-19 Pandemic
title_full_unstemmed 11. Missed Vaccine Opportunities During the COVID-19 Pandemic
title_short 11. Missed Vaccine Opportunities During the COVID-19 Pandemic
title_sort 11. missed vaccine opportunities during the covid-19 pandemic
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776057/
http://dx.doi.org/10.1093/ofid/ofaa439.056
work_keys_str_mv AT shallalanita 11missedvaccineopportunitiesduringthecovid19pandemic
AT vahiaamitt 11missedvaccineopportunitiesduringthecovid19pandemic
AT kenneyrachel 11missedvaccineopportunitiesduringthecovid19pandemic
AT weinmannallisonj 11missedvaccineopportunitiesduringthecovid19pandemic